These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10693696)

  • 1. Glucagonlike peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion.
    Prasad R; Alavi K; Schwartz MZ
    J Pediatr Surg; 2000 Feb; 35(2):357-9. PubMed ID: 10693696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagonlike peptide-2 analogue enhances intestinal mucosal mass and absorptive function after ischemia-reperfusion injury.
    Rajeevprasad R; Alavi K; Schwartz MZ
    J Pediatr Surg; 2000 Nov; 35(11):1537-9. PubMed ID: 11083417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP-2alpha accelerates recovery of mucosal absorptive function after intestinal ischemia/reperfusion.
    Prasad R; Alavi K; Schwartz MZ
    J Pediatr Surg; 2001 Apr; 36(4):570-2. PubMed ID: 11283879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagonlike peptide-2 enhances small intestinal absorptive function and mucosal mass in vivo.
    Kato Y; Yu D; Schwartz MZ
    J Pediatr Surg; 1999 Jan; 34(1):18-20; discussion 20-1. PubMed ID: 10022136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.
    Washizawa N; Gu LH; Gu L; Openo KP; Jones DP; Ziegler TR
    JPEN J Parenter Enteral Nutr; 2004; 28(6):399-409. PubMed ID: 15568286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of glucagon-like peptide 2 on intestinal ischemia-reperfusion rats.
    Zhang W; Zhu W; Zhang J; Li N; Li J
    Microsurgery; 2008; 28(4):285-90. PubMed ID: 18383347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLP-2 augments the adaptive response to massive intestinal resection in rat.
    Scott RB; Kirk D; MacNaughton WK; Meddings JB
    Am J Physiol; 1998 Nov; 275(5):G911-21. PubMed ID: 9815019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is OM-3 synergistic with GLP-2 in intestinal failure?
    Karmaker A; Costanzo CM; Schwartz MZ
    J Surg Res; 2017 Jan; 207():7-12. PubMed ID: 27979490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-2 stimulates gut mucosal growth and immune response in burned rats.
    Chance WT; Sheriff S; McCarter F; Ogle C
    J Burn Care Rehabil; 2001; 22(2):136-43. PubMed ID: 11302602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide 2 is a potent growth factor for small intestine and colon.
    Litvak DA; Hellmich MR; Evers BM; Banker NA; Townsend CM
    J Gastrointest Surg; 1998; 2(2):146-50. PubMed ID: 9834410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-11 enhances intestinal absorptive function after ischemia-reperfusion injury.
    Kuenzler KA; Pearson PY; Schwartz MZ
    J Pediatr Surg; 2002 Mar; 37(3):457-9. PubMed ID: 11877666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats.
    Koopmann MC; Nelson DW; Murali SG; Liu X; Brownfield MS; Holst JJ; Ney DM
    JPEN J Parenter Enteral Nutr; 2008; 32(3):254-65. PubMed ID: 18443137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagonlike peptide-2 analogue: a possible new approach in the management of inflammatory bowel disease.
    Arthur GL; Schwartz MZ; Kuenzler KA; Birbe R
    J Pediatr Surg; 2004 Mar; 39(3):448-52; discussion 448-52. PubMed ID: 15017568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine.
    Lovshin J; Yusta B; Iliopoulos I; Migirdicyan A; Dableh L; Brubaker PL; Drucker DJ
    Endocrinology; 2000 Nov; 141(11):4194-201. PubMed ID: 11089553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncoupling protein 2 involved in protection of glucagon-like peptide 2 in small intestine with ischemia-reperfusion injury in mice.
    Guan L; Gong D; Tian N; Zou Y
    Dig Dis Sci; 2005 Mar; 50(3):554-60. PubMed ID: 15810642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-11 enhances small intestine absorptive function and mucosal mass after intestinal adaptation.
    Alavi K; Prasad R; Lundgren K; Schwartz MZ
    J Pediatr Surg; 2000 Feb; 35(2):371-4. PubMed ID: 10693699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2.
    Brubaker PL; Izzo A; Hill M; Drucker DJ
    Am J Physiol; 1997 Jun; 272(6 Pt 1):E1050-8. PubMed ID: 9227451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2.
    Alavi K; Schwartz MZ; Palazzo JP; Prasad R
    J Pediatr Surg; 2000 Jun; 35(6):847-51. PubMed ID: 10873024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.
    Martin GR; Wallace LE; Sigalet DL
    Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G964-72. PubMed ID: 14962847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-2 protects impaired intestinal mucosal barriers in obstructive jaundice rats.
    Chen J; Dong JT; Li XJ; Gu Y; Cheng ZJ; Cai YK
    World J Gastroenterol; 2015 Jan; 21(2):484-90. PubMed ID: 25593463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.